- Zacks•2 days ago
AbbVie Inc. (ABBV) announced positive results from the phase IIIb study, Garnet, on a combination of its hepatitis drugs Viekirax and Exviera for the treatment of patients with hepatitis C virus (HCV) infection without liver cirrhosis.
- Market Realist•5 days ago
On September 16, 2016, Johnson & Johnson announced the acquisition of Abbott Medical Optics, a subsidiary of Abbott Laboratories, and its stock fell ~0.3%.
Abbott Laboratories (ABT)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||41.93 x 500|
|Ask||42.88 x 200|
|Day's Range||41.56 - 42.33|
|52wk Range||36.00 - 46.38|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||27.94|
|Avg Vol (3m)||9,620,365|
|Dividend & Yield||1.04 (2.50%)|